Canada continues arms exports to Israel unimpeded, exploiting loopholes that allow military goods to flow through the U.S., “unreported and unregulated,” organizer Gur Tsabar, a spokesperson of the ...
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
Investor's Business Daily on MSN4h
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.AbbVie inked a licensing deal Monday worth up to $2.23 billion for an amylin-targeting obesity treatment from Denmark-based ...
The debate around taxation of cruise operators has been around for years. What would the impact be on the cruise lines?
Equities researchers at William Blair increased their FY2026 EPS estimates for argenx in a research note issued on Friday, ...
Investment analysts at William Blair boosted their Q3 2026 earnings per share (EPS) estimates for shares of Salesforce in a ...
William Blair issued their Q1 2026 EPS estimates for Cullinan Therapeutics in a report issued on Thursday, February 27th. William Blair analyst M. Phipps expects that the company will post earnings of ...
William Blair issued their Q1 2026 earnings estimates for shares of Verve Therapeutics in a report issued on Thursday, ...
Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Rocket Pharmaceuticals in a note issued to ...
William Blair issued their Q1 2026 earnings per share estimates for shares of Workday in a report released on Wednesday, ...
Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Entrada Therapeutics in a report issued on Thursday, February 27th. William Blair analyst M. Minter expects that the ...
William Blair restated their outperform rating on shares of Alignment Healthcare (NASDAQ:ALHC – Free Report) in a research report released on Friday,RTT News reports. Several other equities research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback